한글목차

마이크로바이옴 시퀀싱 서비스 시장 동향 및 전망

세계 마이크로바이옴 시퀀싱 서비스 시장은 2023년부터 2028년까지 12.4%의 CAGR로 2028년까지 약 24억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 메타게놈 분석 기술에 대한 수요 증가, 인간 마이크로바이옴 치료제 시장 개척에 대한 높은 집중도, 고급 시퀀싱 장비와 관련된 높은 비용입니다. 세계 마이크로바이옴 시퀀싱 서비스 시장의 미래는 제약회사, 생명공학 기업 및 학술 연구 기관에서 비지니스 기회를 통해 유망한 시장으로 평가받고 있습니다.

마이크로바이옴 시퀀싱 서비스 시장 인사이트

• Lucintel은 수백만 개의 앰프리콘을 동시에 시퀀싱할 수 있는 높은 병렬성과 장, 피부 및 기타 장기의 박테리아 집단(각각 뚜렷한 미생물 지문을 가지고 있음)에 대한 연구에 대한 관심이 높아짐에 따라 합성 시퀀싱(SBS)이 예측 기간 동안 중 가장 높은 성장세를 보일 것으로 예측하고 있습니다. 또한, 일부 영리 기업에서 널리 활용되고 있는 방법이기도 합니다.
• 이 시장에서는 연구 및 학술 분야에서 단백질 및 저분자 검사에 마이크로바이옴 시퀀싱 서비스가 광범위하게 사용되고 있기 때문에 학술 및 연구 기관이 가장 큰 최종 사용 산업 부문으로 남을 것으로 보입니다.
• 북미는 잘 정비된 연구 프레임워크, 최첨단 기술 개발, 그리고 이 지역의 정밀 의약품에 대한 수요 증가로 인해 예측 기간 동안 가장 큰 지역으로 남을 것으로 보입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다:

• Q1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q6. 이 시장의 새로운 트렌드와 그 이유는?
• Q7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2017년부터 2028년까지 시장 동향과 예측 분석

• 거시경제 동향(2017-2022년)과 예측(2023-2028년)
• 세계의 마이크로바이옴 시퀀싱 서비스 시장 동향(2017-2022) 및 예측(2023-2028)
• 기술별 세계 마이크로바이옴 시퀀싱 서비스 시장
  • 합성에 의한 배열 결정(SBS)
  • 결찰에 의한 시퀀싱(SBL)
  • 나노포어 시퀀싱
  • 생어 시퀀싱
  • 기타
• 유형별 세계 마이크로바이옴 시퀀싱 서비스 시장
  • 앰플리콘 배열 결정
  • 전게놈 배열 결정
  • 샷건 시퀀싱
  • 기타
• 최종 이용 산업별 세계 마이크로바이옴 시퀀싱 서비스 시장
  • 제약회사 및 바이오테크놀러지 회사
  • 학술조사기관
  • 기타

제4장 2017년부터 2028년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 마이크로바이옴 시퀀싱 서비스 시장
• 북미의 마이크로바이옴 시퀀싱 서비스 시장
• 유럽의 마이크로바이옴 시퀀싱 서비스 시장
• 유럽의 마이크로바이옴 시퀀싱 서비스 시장
• 아시아태평양 마이크로바이옴 시퀀싱 서비스 시장
• 기타 지역 마이크로바이옴 시퀀싱 서비스 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 기술별 세계의 마이크로바이옴 시퀀싱 서비스 시장 성장 기회
  • 유형별 세계 마이크로바이옴 시퀀싱 서비스 시장 성장 기회
  • 최종 이용 산업별 세계 마이크로바이옴 시퀀싱 서비스 시장 성장 기회
  • 지역별 세계의 마이크로바이옴 시퀀싱 서비스 시장 성장 기회
• 세계의 마이크로바이옴 시퀀싱 서비스 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 마이크로바이옴 시퀀싱 서비스 시장 능력 확대
  • 세계의 마이크로바이옴 시퀀싱 서비스 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Microbiome Insights
• Baseclear
• Clinical-Microbiomics
• Merieux NutriSciences Corporation
• MR DNA
• Metabiomics
• Rancho BioSciences
• Second Genome
• Zymo Research Corporation
• uBiome

영문목차

Microbiome Sequencing Service Market Trends and Forecast

The future of the global microbiome sequencing service market looks promising with opportunities in pharmaceutical and biotechnology companies and academic and research institutes. The global microbiome sequencing service market is expected to reach an estimated $2.4 billion by 2028 with a CAGR of 12.4% from 2023 to 2028. The major drivers for this market are increasing demand for metagenomic sequencing technology, high concentration on development of human microbiome therapeutics, as well as high costs associated with sophisticated sequencing instruments.

A more than 150-page report is developed to help in your business decisions.

Microbiome Sequencing Service Market by Segment

The study includes trends and forecast for the global microbiome sequencing service market by technology, type, and end use industry, and region.

Microbiome Sequencing Service Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

• Sequencing by Synthesis (SBS)
• Sequencing by Ligation (SBL)
• Nanopore Sequencing
• Sanger Sequencing
• Others

Microbiome Sequencing Service Market by Type [Shipment Analysis by Value from 2017 to 2028]:

• Amplicon Sequencing
• Whole-Genome Sequencing
• Shotgun Sequencing
• Others

Microbiome Sequencing Service Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Others

List of Microbiome Sequencing Service Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, microbiome sequencing service companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the microbiome sequencing service companies profiled in this report include:

• Microbiome Insights
• Baseclear
• Clinical-Microbiomics
• Merieux NutriSciences Corporation
• MR DNA
• Metabiomics
• Rancho BioSciences
• Second Genome
• Zymo Research Corporation
• uBiome

Microbiome Sequencing Service Market Insights

• Lucintel forecasts that sequencing by synthesis (SBS) will remain the highest growing segment over the forecast period due to its highly parallel structure that enables the simultaneous sequencing of millions of amplicons and increased interest in studying bacterial populations in the gut, skin, and other organs, each of which has a distinct microbial fingerprint. Moreover, it is an extensively used method by several commercial companies.
• Within this market, academic and research institutes will remain the largest end use industry segment due to extensive utilization of microbiome sequencing services for the examination of proteins and small molecules within the research and academic sectors.
• North America will remain the largest region over the forecast period due to well-developed research framework, cutting-edge technological progress, and the growing need for precision medicines in this region.

Features of the Global Microbiome Sequencing Service Market

• Market Size Estimates: Microbiome sequencing service market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
• Segmentation Analysis: Microbiome sequencing service market size by various segments, such as by technology, type, end use industry, and region in terms of value ($B).
• Regional Analysis: Microbiome sequencing service market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different technologies, types, end use industries, and regions for the microbiome sequencing service market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microbiome sequencing service market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q.1. What is the microbiome sequencing service market size?
• Answer: The global microbiome sequencing service market is expected to reach an estimated $2.4 billion by 2028.
• Q.2. What is the growth forecast for microbiome sequencing service market?
• Answer: The global microbiome sequencing service market is expected to grow with a CAGR of 12.4% from 2023 to 2028
• Q.3. What are the major drivers influencing the growth of the microbiome sequencing service market?
• Answer: The major drivers for this market are increasing demand for metagenomic sequencing technology, high concentration on development of human microbiome therapeutics, as well as high costs associated with sophisticated sequencing instruments.
• Q4. What are the major segments for microbiome sequencing service market?
• Answer: The future of the global microbiome sequencing service market looks promising with opportunities in pharmaceutical and biotechnology companies and academic and research institutes.
• Q5. Who are the key microbiome sequencing service companies?
• Answer: Some of the key microbiome sequencing service companies are as follows:
  • Microbiome Insights
  • Baseclear
  • Clinical-Microbiomics
  • Merieux NutriSciences Corporation
  • MR DNA
  • Metabiomics
  • Rancho BioSciences
  • Second Genome
  • Zymo Research Corporation
  • uBiome
• Q6. Which microbiome sequencing service market segment will be the largest in future?
• Answer: Lucintel forecasts that sequencing by synthesis (SBS) will remain the highest growing segment over the forecast period due to its highly parallel structure that enables the simultaneous sequencing of millions of amplicons and increased interest in studying bacterial populations in the gut, skin, and other organs, each of which has a distinct microbial fingerprint. Moreover, it is an extensively used method by several commercial companies.
• Q7. In microbiome sequencing service market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to well-developed research framework, cutting-edge technological progress, and the growing need for precision medicines in this region.
• Q.8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global microbiome sequencing service market by technology (sequencing by synthesis (SBS), sequencing by ligation (SBL), nanopore sequencing, sanger sequencing, and others), type (amplicon sequencing, whole-genome sequencing, shotgun sequencing, and others), end use industry (pharmaceutical and biotechnology companies, academic and research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Microbiome Sequencing Service Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Global Microbiome Sequencing Service Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Microbiome Sequencing Service Market by Technology
  • 3.3.1: Sequencing by Synthesis (SBS)
  • 3.3.2: Sequencing by Ligation (SBL)
  • 3.3.3: Nanopore Sequencing
  • 3.3.4: Sanger Sequencing
  • 3.3.5: Others
• 3.4: Global Microbiome Sequencing Service Market by Type
  • 3.4.1: Amplicon Sequencing
  • 3.4.2: Whole-Genome Sequencing
  • 3.4.3: Shotgun Sequencing
  • 3.4.4: Others
• 3.5: Global Microbiome Sequencing Service Market by End Use Industry
  • 3.5.1: Pharmaceutical and Biotechnology Companies
  • 3.5.2: Academic and Research Institutes
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Global Microbiome Sequencing Service Market by Region
• 4.2: North American Microbiome Sequencing Service Market
  • 4.2.1: North American Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
  • 4.2.2: North American Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
• 4.3: European Microbiome Sequencing Service Market
• 4.3: European Microbiome Sequencing Service Market
  • 4.3.1: European Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
  • 4.3.2: European Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
• 4.4: APAC Microbiome Sequencing Service Market
  • 4.4.1: APAC Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
  • 4.4.2: APAC Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
• 4.5: ROW Microbiome Sequencing Service Market
  • 4.5.1: ROW Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
  • 4.5.2: ROW Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Microbiome Sequencing Service Market by Technology
  • 6.1.2: Growth Opportunities for the Global Microbiome Sequencing Service Market by Type
  • 6.1.3: Growth Opportunities for the Global Microbiome Sequencing Service Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Microbiome Sequencing Service Market by Region
• 6.2: Emerging Trends in the Global Microbiome Sequencing Service Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Microbiome Sequencing Service Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Microbiome Sequencing Service Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Microbiome Insights
• 7.2: Baseclear
• 7.3: Clinical-Microbiomics
• 7.4: Merieux NutriSciences Corporation
• 7.5: MR DNA
• 7.6: Metabiomics
• 7.7: Rancho BioSciences
• 7.8: Second Genome
• 7.9: Zymo Research Corporation
• 7.10: uBiome